Neutrino Oscillations in Intermediate States.II -- Wave Packets

We analyze oscillations of intermediate neutrinos in terms of the scattering of particles described by Gaussian wave packets. We study a scalar model as in a previous paper (I) but in realistic situations, where the two particles of the initial state and final state are wave packets and neutrinos are in the intermediate state. The oscillation of the intermediate neutrino is found from the time evolution of the total transition probability between the initial state and final state. The effect of a finite lifetime and a finite relaxation time are also studied. We find that the oscillation pattern depends on the magnitude of wave packet sizes of particles in the initial state and final state and the lifetime of the initial particle. For $\Delta m^2_{21}=3\times 10^{-2}$ eV$^2$, the oscillation probability deviates from that of the standard formula if the wave packet sizes are around $10^{-13}$ m for 0.4 MeV neutrino.Comment: 29 pages, 11 figures. typos corrected, appendix adde

Sonic Hedgehog Signaling Pathway in Endothelial Progenitor Cell Biology for Vascular Medicine

The Hedgehog (HH) signaling pathway plays an important role in embryonic and postnatal vascular development and in maintaining the homeostasis of organs. Under physiological conditions, Sonic Hedgehog (SHH), a secreted protein belonging to the HH family, regulates endothelial cell growth, promotes cell migration and stimulates the formation of new blood vessels. The present review highlights recent advances made in the field of SHH signaling in endothelial progenitor cells (EPCs). The canonical and non-canonical SHH signaling pathways in EPCs and endothelial cells (ECs) related to homeostasis, SHH signal transmission by extracellular vesicles (EVs) or exosomes containing single-strand non-coding miRNAs and impaired SHH signaling in cardiovascular diseases are discussed. As a promising therapeutic tool, the possibility of using the SHH signaling pathway for the activation of EPCs in patients suffering from cardiovascular diseases is further explored

Search for TeV gamma-rays from SN 1987A in 2001

We searched for TeV gamma-rays from the remnant of SN 1987A around 5400 days after the supernova. The observations were carried out in 2001, from November 16 to December 11, using the CANGAROO-II Imaging Atmospheric Cherenkov Telescope. In total, 708 minutes of ON- and 1019 minutes of OFF-source data were obtained under good conditions. The detection threshold was estimated to be 1 TeV, due to the mean zenith angle of 39$^\circ$. The upper limits for the gamma-ray flux were obtained and compared with the previous observations and theoretical models. The observations indicate that the gamma-ray luminosity is lower than $1\times 10^{37}$ erg s$^{-1}$ at $\sim 10$ TeV.Comment: 8 pages, 3 figures, submitted for publication, style file adde

Detection of diffuse TeV gamma-ray emission from the nearby starburst galaxy NGC 253

We report the TeV gamma-ray observations of the nearby normal spiral galaxy NGC 253. At a distance of $\sim$2.5 Mpc, NGC 253 is one of the nearest starburst galaxies. This relative closeness, coupled with the high star formation rate in the galaxy, make it a good candidate TeV gamma-ray source. Observations were carried out in 2000 and 2001 with the CANGAROO-II 10 m imaging atmospheric Cerenkov telescope. TeV gamma-ray emission is detected at the $\sim 11\sigma$ level with a flux of $(7.8 \pm 2.5)\times 10^{-12} {\rm cm}^{-2} {\rm sec}^{-1}$ at energies $>$0.5 TeV. The data indicate that the emission region is broader than the point spread function of our telescope.Comment: 4 pages, double colomn, 3 figures, aa.cl

Search for VHE gamma rays from SS433/W50 with the CANGAROO-II telescope

SS433, located at the center of the supernova remnant W50, is a close proximity binary system consisting of a compact star and a normal star. Jets of material are directed outwards from the vicinity of the compact star symmetrically to the east and west. Non-thermal hard X-ray emission is detected from lobes lying on both sides. Shock accelerated electrons are expected to generate sub-TeV gamma rays through the inverse-Compton process in the lobes. Observations of the western X-ray lobe region of SS433/W50 system have been performed to detect sub-TeV gamma-rays using the 10m CANGAROO-II telescope in August and September, 2001, and July and September, 2002. The total observation times are 85.2 hours for ON source, and 80.8 hours for OFF source data. No significant excess of sub-TeV gamma rays has been found at 3 regions of the western X-ray lobe of SS433/W50 system. We have derived 99% confidence level upper limits to the fluxes of gamma rays and have set constraints on the strengths of the magnetic fields assuming the synchrotron/inverse-Compton model for the wide energy range of photon spectrum from radio to TeV. The derived lower limits are 4.3 microgauss for the center of the brightest X-ray emission region and 6.3 microgauss for the far end from SS433 in the western X-ray lobe. In addition, we suggest that the spot-like X-ray emission may provide a major contribution to the hardest X-ray spectrum in the lobe.Comment: 7 pages, 8 figures, to be published in Astroparticle Physic

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

Circulating endothelial cells (CECs) as well as bone-marrow-derived endothelial precursor cells (EPC) play an important role in neovascularisation and tumour growth. To study the impact of neoadjuvant chemotherapy on the amounts of CEC and their precursor cells, mature CEC and their progenitors were quantified by flow cytometry in peripheral blood of breast cancer patients during anthracycline and/or taxane based neoadjuvant chemotherapy and subsequent surgery in comparison to age-matched healthy controls. Cell numbers were tested for correlation with serum levels of angiopoietin-2, erythropoietin, endostatin, endoglin, VEGF and sVCAM-1 as well as clinical and pathological features of breast cancer disease. Circulating endothelial cells were significantly elevated in breast cancer patients and decreased during chemotherapy, whereas EPC (CD34+/VEGFR-2+) as well as their progenitor cell population CD133+/CD34+ and the population of CD34+ stem cells increased. Concomitantly with the increase of progenitor cells an increase of VEGF, erythropoietin and angiopoietin-2 was observed. These data suggest that chemotherapy can only reduce the amounts of mature CEC, probably reflecting detached cells from tumour vessels, whereas the EPC and their progenitors are mobilised by chemotherapy. Since this mobilisation of EPC may contribute to tumour neovascularisation an early antiangiogenic therapy in combination with chemotherapy could be beneficial for the success of cancer therapy

Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model

Therapeutic potential was evaluated in a rat model of myocardial infarction using nanofiber-expanded human cord blood derived hematopoietic stem cells (CD133+/CD34+) genetically modified with VEGF plus PDGF genes (VIP).Myocardial function was monitored every two weeks up to six weeks after therapy. Echocardiography revealed time dependent improvement of left ventricular function evaluated by M-mode, fractional shortening, anterior wall tissue velocity, wall motion score index, strain and strain rate in animals treated with VEGF plus PDGF overexpressed stem cells (VIP) compared to nanofiber expanded cells (Exp), freshly isolated cells (FCB) or media control (Media). Improvement observed was as follows: VIP>Exp> FCB>media. Similar trend was noticed in the exercise capacity of rats on a treadmill. These findings correlated with significantly increased neovascularization in ischemic tissue and markedly reduced infarct area in animals in the VIP group. Stem cells in addition to their usual homing sites such as lung, spleen, bone marrow and liver, also migrated to sites of myocardial ischemia. The improvement of cardiac function correlated with expression of heart tissue connexin 43, a gap junctional protein, and heart tissue angiogenesis related protein molecules like VEGF, pNOS3, NOS2 and GSK3. There was no evidence of upregulation in the molecules of oncogenic potential in genetically modified or other stem cell therapy groups.Regenerative therapy using nanofiber-expanded hematopoietic stem cells with overexpression of VEGF and PDGF has a favorable impact on the improvement of rat myocardial function accompanied by upregulation of tissue connexin 43 and pro-angiogenic molecules after infarction